News tagged with naltrexone

Related topics:

FDA panel recommends approval for Contrave

A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts.

Dec 08, 2010
not rated yet 0

Acamprosate prevents relapse to drinking in alcoholism

Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new Cochrane Systematic Review. The drug showed moderate benefits in trials when used in addition to non-drug treatm ...

Sep 08, 2010
4 / 5 (1) 1

Oral naltrexone can reduce health care costs

Alcohol-use disorders (AUDs), referring to both alcohol abuse and alcohol dependence, affect nearly 8.5 percent of the American population, are associated with numerous medical, psychiatric, family, legal, and work-related ...

Apr 05, 2010
4 / 5 (1) 1

Naltrexone can help heavy social drinkers quit smoking

Naltrexone, an opioid antagonist approved in 1994 by the U.S. Food and Drug Administration for alcohol-dependence (AD) treatment, can reduce relapse rates among AD patients. Research on naltrexone's effectiveness on nicotine ...

Mar 19, 2009
not rated yet 0